news bytes
received the marketing license at the same time.
APCEDEN, an autologous monocyte-derived mature Dendritic cell when loaded with tumor antigen have the ability to generate an effective immune response against the tumor.
Indo-Canadian science programme on clean water technology
The Department of Biotechnology and Department of Science and Technology, Ministry of Science and Technology are collaborating with The India-Canada Centre for Innovation Multidisciplinary Partnerships to Accelerate Community Transformation and Sustainability( IC- IMPACTS), to promote multidisciplinary research partnerships. Five projects addressing the issue of Clean Water Technologies are being implemented by the Departments at the total cost of Rs 5 crore and 72 lakhs with matched funding from Canada. This information was given by Minister of State for Ministry of Science & Technology, Mr Y S Chowdary mentioned in the Parliament recently.
The technologies that are being developed and envisaged as outcomes include the biosensors for detection of toxins, heavy metal detection and removal, biorecovery from waste water( waste to wealth) and survey to identify and explore alternatives in domestic water management.
World’ s first-ever dengue vaccine gets green signal from WHO
The World Health Organization( WHO) has given its nod to the world’ s first-ever vaccine for dengue fever, a potentially deadly mosquito-borne virus that threatens to infect close to half of the world’ s population.
Known as Dengvaxia, the vaccine is the product of two decades of research by Frenchbased Sanofi Pasteur. Four countries— Mexico, Brazil, El Salvador and the Philippines— have already licensed Dengvaxia, but the recommendation on April 14, 2017, will likely spur a host of other developing nations to follow suit at a time when climate change and urbanization is putting increasing numbers of people at risk from the mosquito-borne disease.
“ In countries where dengue is endemic, it’ s one of the most feared diseases. The trajectory globally is increasing at this point, it’ s essentially a pandemic,” Dr In- Kyu Yoon, director of the Dengue Vaccine Initiative, an international consortium that has partnered with Sanofi, was quoted in the international press.
66 BioVoiceNews | May 2017